Nothing Special   »   [go: up one dir, main page]

DE602005022759D1 - Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus - Google Patents

Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus

Info

Publication number
DE602005022759D1
DE602005022759D1 DE602005022759T DE602005022759T DE602005022759D1 DE 602005022759 D1 DE602005022759 D1 DE 602005022759D1 DE 602005022759 T DE602005022759 T DE 602005022759T DE 602005022759 T DE602005022759 T DE 602005022759T DE 602005022759 D1 DE602005022759 D1 DE 602005022759D1
Authority
DE
Germany
Prior art keywords
various types
papilloma virus
acid detection
human papilloma
acidic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022759T
Other languages
English (en)
Inventor
Neeraj Rao
Sylvia A Norman
Jennifer J Bungo
William L Hanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of DE602005022759D1 publication Critical patent/DE602005022759D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE602005022759T 2004-12-08 2005-12-08 Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus Active DE602005022759D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63445804P 2004-12-08 2004-12-08
PCT/US2005/044291 WO2006063065A2 (en) 2004-12-08 2005-12-08 Detection of nucleic acids from multiple types of human papillomaviruses

Publications (1)

Publication Number Publication Date
DE602005022759D1 true DE602005022759D1 (de) 2010-09-16

Family

ID=36578528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022759T Active DE602005022759D1 (de) 2004-12-08 2005-12-08 Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus

Country Status (8)

Country Link
US (19) US7354719B2 (de)
EP (1) EP1819835B1 (de)
JP (9) JP5020825B2 (de)
AT (1) ATE476528T1 (de)
AU (3) AU2005314061B2 (de)
CA (1) CA2588581C (de)
DE (1) DE602005022759D1 (de)
WO (1) WO2006063065A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726047B2 (en) * 1995-11-15 2000-10-26 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
ATE476528T1 (de) 2004-12-08 2010-08-15 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
EP1997914A1 (de) * 2007-06-01 2008-12-03 Università Degli Studi Di Milano - Bicocca Identifizierung und Quantifizierung onkogener HPV-Nukleinsäuren mittels PCR-Assays in Echtzeit
JP5313157B2 (ja) * 2007-10-19 2013-10-09 栄研化学株式会社 核酸増幅法、それに用いる試薬及び試薬キット
SI2209920T1 (sl) * 2007-11-01 2016-10-28 Self-Screen B.V. Nov postopek odkrivanja za HPV-je materničnega vratu
CN102209793B (zh) * 2008-11-19 2014-09-03 达雅高生物科技有限公司 用于检测hpv的核苷酸序列、方法和试剂盒
AU2010217928B2 (en) 2009-02-26 2013-06-06 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
EP2427763A4 (de) 2009-05-07 2013-08-21 Oncohealth Corp Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
US9410189B2 (en) * 2010-04-30 2016-08-09 Co-Diagnostics, Inc. Methods of preventing non-specific reactions of nucleotide sequences
EP2576840B1 (de) 2010-05-25 2018-10-17 QIAGEN Gaithersburg, Inc. Hybrid-capture-assay mit schneller ergebnislieferung und zugehörige strategisch gekürzte sonden
EP2455658B1 (de) 2010-11-17 2016-03-02 Orcan Energy AG Verfahren und Vorrichtung zur Verdampfung organischer Arbeitsmedien
AU2013205122B2 (en) 2012-10-11 2016-11-10 Gen-Probe Incorporated Compositions and Methods for Detecting Human Papillomavirus Nucleic Acid
CN103409560A (zh) * 2013-08-19 2013-11-27 潘晓静 一种广谱、高效、经济的高危人乳头状瘤病毒的pcr检测方法
CN113122535A (zh) * 2015-09-10 2021-07-16 株式会社钟化 从含有核酸的样品中分离核酸的方法及用于该方法的样品处理试剂
AU2018369872B2 (en) * 2017-11-17 2022-11-24 Gen-Probe Incorporated Compositions and methods for detecting C1orf43 nucleic acid
EP4067471A4 (de) 2019-11-26 2024-06-26 Yokogawa Electric Corporation Spitzenvorrichtung, spitzenbehältersatz, spitzenelektrodenvorrichtung und spitzenelektrodensatz
IL296509A (en) * 2020-03-16 2022-11-01 Univ North Carolina Chapel Hill Preparations and methods for selective detection of tumor-derived viral DNA
CN114020363B (zh) * 2021-11-15 2023-12-15 海能达通信股份有限公司 群组附着方法及相应设备
WO2024081776A1 (en) * 2022-10-13 2024-04-18 Gen-Probe Incorporated Cellularity control for nucleic acid assays

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876922A (en) * 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
US5411857A (en) * 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
CA1276575C (fr) * 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
JP2633275B2 (ja) 1986-03-21 1997-07-23 アンステイテユ・パストウール 乳頭腫ウイルス（ｈｐｖ）―３３のゲノムに由来するｄｎａ又はそのｄｎａ断片
US5783412A (en) * 1987-02-26 1998-07-21 Biosearch International Pty. Ltd. Method of detection of carcinogenic human papillomavirus
US4849331A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
US4849332A (en) * 1987-05-26 1989-07-18 Life Technologies, Inc. Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same
US4849334A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
US4908306A (en) * 1987-06-12 1990-03-13 Life Technologies, Inc. Human papillomavirus 56 nucleic acid hybridization probes and methods for employing the same
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
EP0338067A4 (en) * 1987-10-02 1991-05-02 Microprobe Corporation Human papillomavirus type diagnosis with nucleotide probes
US5030557A (en) * 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
FR2627590A1 (fr) 1988-02-24 1989-08-25 Ire Celltarg Sa Sonde d'acides nucleiques comportant un nucleotide terminal modifie chimiquement en 5(prime) (oh) en vue de son marquage non radioactif et procedes de preparation
FR2632956B2 (fr) * 1988-05-13 1991-07-12 Pasteur Institut Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) * 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
DE3838269A1 (de) * 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
JP2791685B2 (ja) 1989-06-08 1998-08-27 寳酒造株式会社 パピローマウイルスの検出方法
AU6966991A (en) * 1989-12-01 1991-06-26 Gene-Trak Systems Detection of hpv transcripts
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
JP2785164B2 (ja) 1990-08-20 1998-08-13 寳酒造株式会社 ヒトパピローマウイルスの検出方法
US5484699A (en) * 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
FR2678284B1 (fr) * 1991-06-28 1993-10-08 Pasteur Institut Sequences d'adn derivees du genome du papillomavirus hpv42, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus et a la production de compositions immunogenes.
ZA929351B (en) * 1991-12-11 1993-06-04 Igen Inc Electrochemiluminescent label for DNA assays.
EP1288296A3 (de) 1992-05-11 2003-03-12 Ribozyme Pharmaceuticals, Inc. Verfahren und Reagenz zur Hemmung der HBV viralen Replikation
ZA936016B (en) * 1992-08-24 1994-03-10 Akzo Nv Method for nucleic acid amplification
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
US5618536A (en) 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
AU6945694A (en) 1993-05-06 1994-12-12 Dade International Inc. Human papillomavirus detection assay
US6174668B1 (en) * 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
US5679509A (en) * 1993-09-28 1997-10-21 University Of New Mexico Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer
AUPM566794A0 (en) * 1994-05-17 1994-06-09 University Of Queensland, The Process and product
HUT77337A (hu) * 1994-09-22 1998-03-30 Merck & Co. Inc. Humán papillomavírus 6A-típusát kódoló DNS
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
DE19506561C1 (de) * 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
IL117591A0 (en) * 1995-03-30 1996-07-23 Merck & Co Inc Synthetic DNA encoding human papillomavirus type 11 L1 protein
AU726047B2 (en) * 1995-11-15 2000-10-26 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US5981173A (en) 1996-02-14 1999-11-09 Institut Pasteur Genital human papillomavirus type 68a (HPV-68a), related to the potentially oncogenic HPV-39
WO1997039010A1 (en) * 1996-04-15 1997-10-23 The University Of New Mexico Probes for the detection of human papillomavirus
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
EP1038022B1 (de) * 1997-12-12 2005-07-20 Digene Corporation Bewertung von humaner papillomvirus verwandter krankheit
US7494658B2 (en) * 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
WO2000014244A2 (en) * 1998-09-04 2000-03-16 Connaught Laboratories Limited Treatment of cervical cancer
US6313373B1 (en) * 1998-10-30 2001-11-06 Case Western Reserve University Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
EP1006199A1 (de) * 1998-12-03 2000-06-07 Kreatech Biotechnology B.V. Verfahren zur Herstellung von Verknüpfungen an ausgewählten Positionen von Nukleinsäuresträngen und deren Verwendung
SE515668C2 (sv) 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
DE60043789D1 (de) * 1999-07-09 2010-03-18 Gen Probe Inc HIV-1 Detektion mittels Nukleinsäureamplifizierung
WO2001029233A2 (en) 1999-10-20 2001-04-26 The Johns Hopkins University School Of Medicine Chimeric immunogenic compositions and nucleic acids encoding them
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
AU2074201A (en) 1999-12-08 2001-06-18 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
DE10009143B4 (de) * 2000-02-26 2012-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum Nachweis von Humanen Papillomviren
US6936443B2 (en) * 2000-04-03 2005-08-30 Cytyc Corporation Detection and typing of human papillomavirus using PNA probes
JP2001321168A (ja) 2000-05-12 2001-11-20 Toshiyuki Sasagawa Ｈｐｖ感染型の同定方法
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
GB0018050D0 (en) * 2000-07-21 2000-09-13 Norchip As Detection of human papillomavirus mRNA
DE10059630A1 (de) * 2000-12-01 2002-06-06 Medigene Ag Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
US7374945B2 (en) * 2000-12-14 2008-05-20 Gen-Probe Incorporated Method for enhancing the association rates of polynucleotides
US20060057561A1 (en) * 2001-06-14 2006-03-16 Hart Keith W Virus detection method, primers therefor and screening kit
EP1415007A2 (de) * 2001-08-08 2004-05-06 GlaxoSmithKline Biologicals S.A. Verfahren zur kennzeichnung von art-spezifischen polynukleotidesequenzen
US6884605B2 (en) * 2001-08-09 2005-04-26 Board Of Trustees Of The University Of Arkansas Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
GB0120938D0 (en) 2001-08-29 2001-10-17 Norchip As Detection of human papillomavirus E7 mRNA
GB0200258D0 (en) * 2002-01-07 2002-02-20 Norchip As Detection of human papillomavirus
IL162722A0 (en) * 2002-01-07 2005-11-20 Norchip As Method for detecting human papillomarirus mrna
US7740871B2 (en) * 2002-09-19 2010-06-22 Johns Hopkins University School Of Medicine Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
SE0202897D0 (sv) * 2002-10-01 2002-10-01 Quantovir Ab Method and kit for quantitative and qualitative determination of human papillomavirus
ES2391451T3 (es) 2002-10-03 2012-11-26 Wyeth Holdings Corporation Péptidos de fusión que comprenden los polipéptidos E7 y E6 de virus del papiloma humano y composiciones inmunogénicas de los mismos
AU2004275865B2 (en) * 2003-09-25 2008-09-25 Third Wave Technologies, Inc. Detection of HPV
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
ATE466107T1 (de) 2004-07-01 2010-05-15 Gen Probe Inc Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
ATE476528T1 (de) * 2004-12-08 2010-08-15 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
US20060134615A1 (en) * 2004-12-20 2006-06-22 James Linder Method for the simultaneous detection of HPV RNA and DNA in a sample
US7524631B2 (en) * 2005-02-02 2009-04-28 Patterson Bruce K HPV E6, E7 mRNA assay and methods of use thereof
US20070111960A1 (en) * 2005-03-04 2007-05-17 Advandx, Inc. High affinity probes for analysis of human papillomavirus expression
JP6076679B2 (ja) * 2012-10-15 2017-02-08 ナカ工業株式会社 手摺笠木

Also Published As

Publication number Publication date
JP6857632B2 (ja) 2021-04-14
JP6128705B2 (ja) 2017-05-17
US20150094235A1 (en) 2015-04-02
US20140342351A1 (en) 2014-11-20
CA2588581C (en) 2011-05-31
US8026066B2 (en) 2011-09-27
JP6038067B2 (ja) 2016-12-07
JP5020825B2 (ja) 2012-09-05
AU2005314061B2 (en) 2010-01-28
US8835114B2 (en) 2014-09-16
CA2588581A1 (en) 2006-06-15
US11624096B2 (en) 2023-04-11
US20190376152A1 (en) 2019-12-12
JP2016025875A (ja) 2016-02-12
US20190002995A1 (en) 2019-01-03
US20140030701A1 (en) 2014-01-30
AU2005314061A1 (en) 2006-06-15
AU2010201656B2 (en) 2012-03-15
JP2014138615A (ja) 2014-07-31
US20060121516A1 (en) 2006-06-08
US9074263B2 (en) 2015-07-07
WO2006063065A2 (en) 2006-06-15
EP1819835A4 (de) 2009-09-02
US20200032355A1 (en) 2020-01-30
AU2012203392A1 (en) 2012-06-28
US20150292046A1 (en) 2015-10-15
US10968494B2 (en) 2021-04-06
JP6590857B2 (ja) 2019-10-16
EP1819835A2 (de) 2007-08-22
US20080311559A1 (en) 2008-12-18
US7354719B2 (en) 2008-04-08
US11359252B2 (en) 2022-06-14
US20140024021A1 (en) 2014-01-23
US20180002768A1 (en) 2018-01-04
JP2019213560A (ja) 2019-12-19
US7682792B2 (en) 2010-03-23
US10465255B2 (en) 2019-11-05
US20140038173A1 (en) 2014-02-06
US20130078618A1 (en) 2013-03-28
JP2008522620A (ja) 2008-07-03
US10640836B2 (en) 2020-05-05
US8828660B2 (en) 2014-09-09
JP2023083425A (ja) 2023-06-15
JP2012165751A (ja) 2012-09-06
JP2017113038A (ja) 2017-06-29
AU2010201656A1 (en) 2010-05-20
US8334098B2 (en) 2012-12-18
US10711317B2 (en) 2020-07-14
US9328392B2 (en) 2016-05-03
EP1819835B1 (de) 2010-08-04
AU2012203392B2 (en) 2013-09-12
US20210010095A1 (en) 2021-01-14
US20110311961A1 (en) 2011-12-22
US20210164063A1 (en) 2021-06-03
JP2018138061A (ja) 2018-09-06
US20100105027A1 (en) 2010-04-29
US9765407B2 (en) 2017-09-19
US20200165689A1 (en) 2020-05-28
US20150292047A1 (en) 2015-10-15
JP2021176306A (ja) 2021-11-11
US8785125B2 (en) 2014-07-22
ATE476528T1 (de) 2010-08-15
WO2006063065A3 (en) 2008-07-31
US11613788B2 (en) 2023-03-28
JP5648016B2 (ja) 2015-01-07
US10047407B2 (en) 2018-08-14
US8574841B2 (en) 2013-11-05

Similar Documents

Publication Publication Date Title
DE602005022759D1 (de) Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
EP2471805A3 (de) Zusammensetzungen und Verfahren zur spezifischen Detektion von Nukleinsäuren der Viren Influenza A oder B
EA201170933A1 (ru) Анализ нуклеиновых кислот, полученных из единичных клеток
MX2012002411A (es) Metodos de ensayo para el mdv-1.
Fozouni et al. Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone
EP1578952A4 (de) Direkter snp-nachweis mit nichtamplifizierter dna
DE60120501D1 (de) mRNA AMPLIFIZIERUNG
WO2007021250A3 (en) Method and/or apparatus of oligonucleotide design and/or nucleic acid detection
EP4105644A3 (de) Systeme und vorrichtungen zur "sequence-by-synthesis"-analyse
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
GB2445529A (en) Method for isothermal amplification of nucleic acids and method for detecting nucleic acids using simultaneous isothermal amplification of nucleic acids
NZ601652A (en) Set of probes for the detection and typing of 46 human papillomavirus mucosal types
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
ATE456668T1 (de) Nachweis und typisierung des papillomavirus mittels pna-sonden
Huang et al. dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation
WO2007017699A3 (en) In vitro diagnostic kit for identification of human papillomavirus in clinical samples
WO2010072822A3 (de) Präparation und amplifikation von nukleinsäuren mittels magnetischer partikel
EP1988178A3 (de) Nukleotid-Primer-Set und Nukleotidsonde für den Nachweis des Serum-Amyloid A1 (SAA1)-Genotyps
RU2014122607A (ru) Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома
Leal Jr et al. Current and emerging molecular tests for human papillomavirus–related neoplasia in the genomic era
Geraldi et al. Synthetic biology-based portable in vitro diagnostic platforms
WO2010099378A3 (en) Assay for detection of human parvovirus nucleic acid
EP2402465A3 (de) Zusammensetzungen und Verfahren zur Detektion von Hepatitis-A-Virus-Nukleinsäure
EA201491821A1 (ru) Модифицированные олигонуклеотиды, включающие тиольные функциональные группы, и их применение для детекции нуклеиновых кислот
Lace et al. Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration